Fulvestrant looks on track to fulfil expectations in advanced breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1315, 2001-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer

By Robertson J.F.R.  

Clinical Pharmacokinetics, Vol. 43, Iss. 8, 2004-01 ,pp. : 529-538

Adis International

Access to resources Recommend Favorite

Fulvestrant as EFECTive as exemestane in advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Fulvestrant: benefits at acceptable costs in advanced breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Fulvestrant – a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer

By Possinger Kurt  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2549-2558

Informa Healthcare

Access to resources Recommend Favorite

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer

By Scott Sarah M   Brown Myles   Come Steven E  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 819-826

Informa Healthcare

Access to resources Recommend Favorite